Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Cambridge Consultants Advises Cambridge University's Tech Transfer Arm On IP Strategy
A multidisciplinary team of technology strategists and scientists from Cambridge Consultants has provided advice to Cambridge Enterprise Ltd., regarding potential applications for microdroplet technology in a high-growth sector of the drug discovery market, currently valued at US$140m.

The AGA Foundation Awards Grant To Dr. Michael Choi To Further His Research On Carcinoid Tumors
The AGA Foundation for Digestive Health and Nutrition (FDHN) has named Michael Y. Choi , MD, the first recipient of the Mary Terese Hartzheim Award for Neuroendocrine Tumor Research. This new research award was created for young investigators interested in researching carcinoid or neuroendocrine tumors. Dr. Choi is an investigator at Massachusetts General Hospital and an instructor of medicine at Harvard Medical School, Boston. He was previously named an AGA Foundation Research Scholar Award recipient in 2005.
News of the day
Obama, Pope Focus On Abortion, 'Life' Issues In First Meeting
In their first meeting, President Obama and Pope Benedict XVI on Friday discussed their views on abortion, embryonic stem cell research and the rights of health care workers to object to procedures and services that go against their beliefs, the Los Angeles Times reports. During a 30-minute discussion, the pope expressed to Obama his beliefs about "the defense and promotion of life and the right to abide by one"s conscience," according to the Vatican. The Times reports that the statement was a "clear reference" to debates over abortion rights, embryonic stem cell research and "conscience" protections for health care providers who refuse care on moral or religious grounds (Chu, Los Angeles Times, 7/11).According to Time, Benedict showed "no intention of papering over differences on what the Vatican calls "life" issues," including abortion rights. Vatican spokesperson the Rev. Federico Lombardi said that the pope told him how Obama "explicitly expressed his commitment to reducing the number of abortions and to listen to the Church"s concerns on moral issues" (Israely, Time, 7/10). According to White House deputy national security aide Denis McDonough, Obama was "eager to find common ground on these issues and to work aggressively to do that" (Simpson/Feller, AP/Boston Globe, 7/11). However, "[I]t may just be that there"s issues that you can"t come to agreement on," McDonough added, noting that Obama believes that "you can disagree without being disagreeable" (Los Angeles Times, 7/11).Montsignor Georg Ganswein, the pope"s personal secretary, said that Obama was given a copy of "Dignitas Personae," or "The Dignity of a Person," a Vatican document released in December detailing the Roman Catholic Church"s most recent stance on bioethics issues (Time, 7/10). The document "hardened" the Church"s opposition to embryonic stem cell research, cloning and in vitro fertilization (AP/Boston Globe, 7/11). Obama assured the pope he would read the document that day on his flight from Italy to Ghana. Ganswein said that the document "can help the president better understand the position of the Catholic Church." Lombardi noted that it "would be ambiguous to hide or minimize what we believe," adding, "It"s not meant to be divisive or polemical" (Time, 7/10).
Health Insurance

Changes To HPA Pandemic Flu Media Updates, UK

Government"s announcement that the UK is moving to a new phase in the response to the current pandemic flu virus means there will be a change to the surveillance information that the Health Protection Agency will be able to provide to the media in future. The Agency has been carrying out laboratory testing of suspected cases of pandemic flu (H1N1v) since the outbreak came to light in April. The Agency"s daily update has been based, since then, on the number of positive test results being confirmed through the Centre for Infections and the Agency"s regional network of laboratories. The new policy moves from measures to try and contain the pandemic flu virus to focussing on providing appropriate treatment to people with H1N1v flu. This means that, nationally, clinicians will now rely on patients" symptoms rather than laboratory tests to diagnose illness. Although we will continue to test a proportion of patients to ensure we keep getting up to date information about the virus, the daily reporting of laboratory confirmations will no longer be an accurate way to record the spread of infection, as it will not include the vast majority of cases. The HPA will, therefore, no longer be providing a daily update of the numbers of cases confirmed through laboratory tests. From next week, the Health Protection Agency"s Centre for Infections press office will instead issue a weekly media alert covering the various surveillance systems the Agency will be using to monitor the ongoing situation. This will also be available in the News section of the Agency"s website at http://www.hpa.org.uk. The exact day these new weekly alerts will start will be confirmed next week. This country has well established, and internationally respected, surveillance systems for monitoring the levels and impact of flu, which have operated through the "normal flu season" over the last few years. These systems have proved effective for informing policy and planning and are included in existing pandemic preparedness plans as central to surveillance in a pandemic situation. These existing systems will be augmented by additional surveillance activities, relevant to the H1N1 pandemic situation, that will continually assess the severity of disease associated with this novel virus and monitor changes in the characteristics of the virus. The approach to surveillance in this new treatment phase will not provide a definitive figure of the number of cases nationally or regionally at any one time, as this will no longer be possible when widespread laboratory testing ceases. Instead, the updates will be providing a variety of indicators of overall flu activity in the population (i.e. aggregate measures of rates of illness). This will be supported by sample-based surveillance to detect and monitor particular characteristics of the virus or the illness that it causes. This is broadly the same approach as is taken to monitoring seasonal flu. This surveillance will provide: - The collection of data from a network of GP surgeries across the country which provide consultation rates for patients presenting with flu-like illness. - A "syndromic surveillance" system, operated by NHS Direct in collaboration with HPA, which provides information on numbers of callers reporting cold/ flu symptoms and fever. - Data from sample laboratory testing of some patients from community and hospital s, providing information on the flu virus types circulating in the community. The Agency has used this set of very comprehensive surveillance mechanisms over many flu seasons to accurately predict flu levels, monitor new and emerging viruses and identify trends in activity. This experience means we can confidently continue to monitor the incidence and distribution of this pandemic virus over the summer and beyond. The agency remains committed to keeping people up to date with the current situation on swine flu. Further information on swine flu is available on the Health Protection Agency"s website at http://www.hpa.org.uk/swineflu. Health Protection Agency


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009